Y, L., T, H., M, L., Q, W., W, H., & J, Z. (2023). Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation. Clinical Pharmacology: Advances and Applications, ume 15, 113-123.
Chicago Style (17th ed.) CitationY, Li, Hu T, Lin M, Wang Q, Han W, and Zhong J. "Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation." Clinical Pharmacology: Advances and Applications ume 15 (2023): 113-123.
MLA (9th ed.) CitationY, Li, et al. "Comparison of Efficacy and Safety Between Dronedarone and Amiodarone Used During the Blind Period in Patients with Atrial Fibrillation After Catheter Ablation." Clinical Pharmacology: Advances and Applications, vol. ume 15, 2023, pp. 113-123.